Comprehensive Study Guide to the Complement System: Pathways, Regulation, and Biological Functions

Historical Discovery and Fundamentals of the Complement System

The complement system was first identified in 1890 when researchers discovered that the mere fixation of antibodies was insufficient to eliminate an antigen. Scientists Pfeiffer and Bordet demonstrated the existence of a supplementary serum system required to destroy Gram-negative bacteria and erythrocytes, leading to the conceptualization of the "complement." This system is defined as a complex biological network comprising numerous serum globulins. These proteins operate through a sequential activation process, primarily following two distinct pathways: the classical pathway, which is triggered by the formation of an antigen-antibody complex, and the alternative pathway, which is activated by the direct presence of bacterial molecules. The ultimate goal of this sequential activation is a series of biological activities designed to eliminate foreign substances from the body. The system includes 9 elementary proteins for the classical pathway, including one trimolecular complex, and 5 specific proteins for the alternative pathway. Many of these proteins exist as proenzymes that activate in a cascading chain reaction.

Molecular Nomenclature and Properties of Complement Proteins

Proteins within the complement system are identified by specific naming conventions. For the classical pathway, components are denoted with the letter C followed by a number. When these molecules form a complex, they are written as a single unit, such as $C1,4,2$. In the alternative pathway, the primary proteins are designated as Factors B, H, I, D, and P. A standard convention exists for protein fragments: when a protein is cleaved, the larger fragment that typically acquires biological activity is designated with the letter "b," while the smaller fragment is designated with the letter "a." For example, the activation of $C4$ results in $C4b$, the larger active fragment, and $C4a$. The molecules must interact in a specific, determined order to facilitate the sequential steps of fixation, cascade activation, and final attack on the antigen. The formation of these reversible molecular complexes often depends on specific environmental conditions, particularly the presence of divalent cations such as $Ca^{2+}$ and $Mg^{2+}$.

Cellular Origin and the Initiation of the Classical Pathway

The proteins of the complement system are synthesized primarily by hepatocytes, intestinal epithelial cells, and monocytes or macrophages. Activation usually occurs through the cleavage of a proenzyme, which then gains the ability to activate the next protein in the sequence. The classical pathway is specifically initiated by an antigen-antibody complex. The process begins with $C1$, a trimolecular complex composed of subunits $C1q$, $C1r$, and $C1s$, where $C1q$ serves as the structural framework. The C-terminal ends of $C1q$ bind to the constant region of immunoglobulins. This fixation is most effective with $IgM$, though it can also occur with $IgG1$, $IgG3$, and occasionally $IgG2$. For successful activation, at least one molecule of $IgM$ or two closely positioned $IgG$ molecules are required. Once $C1q$ is fixed, $C1r$ is activated, which then clives and activates $C1s$, granting it esterase activity to hydrolyze subsequent molecules.

Formation of Convertases and the Amplification Loop

Once $C1s$ is activated, it performs the lysis of $C4$ and $C2$ in the presence of calcium. $C4b$ attaches to the antigen membrane while $C4a$ is released. Subsequently, $C2a$ binds to $C4b$ to form the $C4b2a$ complex, while $C2b$ is released. This $C4b2a$ complex serves as the $C3$-convertase, responsible for activating $C3$. When $C3$ is cleaved, $C3b$ can either bind to the $C4b2a$ complex to form $C4b2a3b$ (the $C5$-convertase) or bind directly to the antigen membrane, a process known as opsonization. Opsonization coats the antigen in $C3b$, making it easily recognizable to immune cells with corresponding receptors, thereby facilitating phagocytosis. The fragments released during these steps, such as $C3a$, $C4a$, and $C2b$, are known as anaphylatoxins. These molecules play critical roles in inflammation by increasing blood flow, stimulating smooth muscle contraction, and attracting immune cells. To prevent self-damage, the system is regulated by inhibitors that inactivate $C4b$ if it fails to fix to a membrane, as well as inhibitors for $C1$ and the short half-life of $C3$-convertase.

The Alternative Pathway and the Cobra Venom Paradox

Unlike the classical pathway, the alternative pathway does not require an antigen-antibody complex for initiation. It is triggered by the surface polysaccharides of certain microorganisms, bacterial endotoxins, yeast glucans, or cobra venom. In this pathway, small amounts of $C3b$ fix to the antigen surface. Factor B then binds to this $C3b$, making it susceptible to cleavage by Factor D. This results in the $C3bBb$ complex, which acts as the alternative $C3$-convertase to amplify the activation of $C3$. As more $C3b$ molecules accumulate, the complex $(C3b)_nBb$ acquires $C5$-convertase activity, a state stabilized by Factor P (Properdin). Regulation is maintained by Factor H, which prevents excessive $C3bB$ formation, and Factor I, which lyses free serum $C3b$. A notable exception is cobra venom, which contains a form of $C3b$ that does not bind Factors H or I. This leads to a long-lived, uninhibited complex with Factor B, causing massive, generalized inflammation and the destruction of the body's own cells, a state known as anaphylactic shock.

The Membrane Attack Complex and Terminal Lysis

The terminal stage of both pathways is the formation of the Membrane Attack Complex (MAC). This begins when $C5$-convertase ($C4b2a3b$ in the classical pathway or $(C3b)_nBb$ in the alternative) clives $C5$. The resulting $C5b$ fragment fixes to the membrane and recruits $C6$ and $C7$, inducing a conformational change. This allows $C8$ to bind; $C8$ possesses a hydrophobic domain that enables it to insert directly into the antigen's lipid bilayer. Finally, multiple $C9$ proteins polymerize around the site to stabilize a hole, creating a functional pore in the membrane. This pore disrupts the osmotic balance of the target cell, particularly Gram-negative bacteria, leading to cytolysis. To protect host cells from accidental MAC formation, membrane proteins such as $CD55$ and $CD46$ limit the fixation of $C3$, while $CD59$ specifically inhibits the fixation of $C9$.

Complement Receptors and Cellular Communication

Complement receptors (CR), formerly known as cluster of differentiation (CD) molecules, are located on the surfaces of various immune cells to mediate the effects of opsonization and phagocytosis. $CR1$ ($CD35$) binds to $C3b$ and $C4b$ and is found on T lymphocytes, red blood cells, neutrophils, and monocytes/macrophages; it facilitates the degradation of these fragments and the transport of immune complexes by red blood cells. $CR2$ ($CD21$) is located on B lymphocytes and epithelial cells of the cervix and nasopharynx; it binds inhibited $C3b$ ($iC3b$) and acts as a receptor for the Epstein-Barr Virus (EBV). $CR3$ ($CD11b$) and $CR4$ ($CD11c$) both bind to $iC3b$ and are primarily found on monocytes, macrophages, and neutrophils (with $CR4$ especially on neutrophils), where they stimulate active phagocytosis.

Physiological Roles in Immunity and Homeostasis

The complement system serves four major roles in the body's defense. First, it facilitates phagocytosis through opsonization, mainly via $C3b$, which requires a secondary signal from $C5a$ or the antibody Fc region to trigger digestion. Second, it orchestrates local inflammation; anaphylatoxins like $C3a, C4a,$ and especially $C5a$ stimulate chemotaxis and cause mast cells and basophils to degranulate. This leads to vasodilation and increased vascular permeability, allowing leukocytes to enter tissues via diapedesis. Third, it promotes cytolysis of Gram-negative bacteria through the MAC, allowing serum lysozymes to access and destroy the inner bacterial wall. Fourth, it manages the elimination of immune complexes; these complexes are tagged with $C3b$ and $C4b$, allowing red blood cells to capture and transport them to the liver or spleen, where they are stripped and degraded by macrophages. Finally, the system enhances the humoral response by increasing antigen availability to antigen-presenting cells, including B lymphocytes.